According to recent scientific studies, persistent inflammation either hastens or even initiates Alzheimer’s disease process. The prevalence of Alzheimer’s disease appears to be much lower among older adults who routinely take anti-inflammatory medications, according to several epidemiological research.
What is Alzheimer’s Disease?
Alzheimer’s disease is a condition that affects the cognitive regions of the brain. It is degenerative and gradually impairs short- and long-term memory, ultimately preventing the sufferer from completing routine everyday activities. Dementia (a generic term used to describe the loss of cognitive function severe enough to interfere with executing tasks in daily life) is currently understood to have Alzheimer’s as its most common underlying cause.
Although it typically affects people over the age of 65, this gradual degenerative disease is not a normal aspect of ageing. It is thought that the disease has already left its imprint on the microscopic level of the brain long before any symptoms manifest. Patients with Alzheimer’s disease often pass away four to eight years following their diagnosis. This condition is degenerative and progressive because it gradually impairs brain function and, eventually, human life.
Short-term memory loss will start to affect Alzheimer’s patients, typically starting with little, insignificant gaps. Both short-term memory and long-term memory get elusive with age. A conversation becomes impossible as the disease progresses and takes control of the patient’s brain since they are unable to respond to their surroundings.
Alzheimer’s disease currently has no known allopathic medicinal treatment. Patients and their families get management skills for the degenerative illness that causes brain neuron death and ultimately results in death. Exciting advancements in biomedical research show the potential benefits of whole body cryotherapy as a preventive measure and, ultimately, as a means of symptom eradication.